Overview

Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101

Status:
Completed
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
The investigation of the long-term safety and maintenance of efficacy of ATX-101 in reduction of submental fat.
Phase:
Phase 3
Details
Lead Sponsor:
Kythera Biopharmaceuticals